Literature DB >> 25538861

Management of Concurrent Pregnancy and Acute Lymphoblastic Malignancy in Teenaged Patients: Two Illustrative Cases and Review of the Literature.

Alia Zaidi1, Liza-Marie Johnson2, Christopher L Church3, Wendy C Gomez-Garcia4, Marcela I Popescu5, Judith F Margolin6, Raul C Ribeiro2.   

Abstract

The usual age range of acute lymphoblastic malignancies (acute lymphoblastic leukemia and advanced-stage lymphoblastic lymphoma) includes teenagers and young adults (<22 years of age) and coincides with the age of fertility. Concurrence of acute lymphoblastic malignancy with pregnancy is therefore most likely to happen during the younger childbearing ages. However, the therapeutic challenges posed by the dual diagnosis of lymphoblastic malignancy and pregnancy have not specifically been studied in the context of age, and management guidelines for pregnant young patients are lacking. Inconsistency in defining the legal decision-making rights of pregnant teenaged patients adds a further level of complexity in this age group. Management of this challenging combination in the young patient therefore entails unique ethical considerations. Here we present two illustrative cases of teenage pregnancy complicated by acute lymphoblastic malignancy, review the available literature, and offer suggestions for the therapeutic management of such cases in adolescent and young adult patients. Importantly, practical management recommendations are provided in the context of clinical ethics principles that are universally applicable, including in developing countries, where the highest incidence of adolescent pregnancies has been documented.

Entities:  

Keywords:  acute lymphoblastic leukemia; chemotherapy; lymphoma; pregnancy; teenager; teratogenicity

Year:  2014        PMID: 25538861      PMCID: PMC4270130          DOI: 10.1089/jayao.2014.0014

Source DB:  PubMed          Journal:  J Adolesc Young Adult Oncol        ISSN: 2156-5333            Impact factor:   2.223


  62 in total

Review 1.  Drugs in pregnancy. Pharmacokinetics in pregnancy.

Authors:  M Dawes; P J Chowienczyk
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2001-12       Impact factor: 5.237

Review 2.  Cancer in pregnancy: maternal and fetal implications.

Authors:  B Weisz; E Schiff; M Lishner
Journal:  Hum Reprod Update       Date:  2001 Jul-Aug       Impact factor: 15.610

Review 3.  Medical progress. Congenital malformations: etiologic factors and their role in prevention (first of two parts).

Authors:  H Kalter; J Warkany
Journal:  N Engl J Med       Date:  1983-02-24       Impact factor: 91.245

4.  Hematological malignancies and pregnancy: treat or no treat during first trimester.

Authors:  Agustin Avilés; Natividad Neri; María-Jesús Nambo
Journal:  Int J Cancer       Date:  2012-04-18       Impact factor: 7.396

Review 5.  Acute leukemia during pregnancy: a report on 37 patients and a review of the literature.

Authors:  Youcef Chelghoum; Norbert Vey; Emmanuel Raffoux; Françoise Huguet; Arnaud Pigneux; Brigitte Witz; Cécile Pautas; Stéphane de Botton; Denis Guyotat; Bruno Lioure; Nathalie Fegueux; Frédéric Garban; Hussam Saad; Xavier Thomas
Journal:  Cancer       Date:  2005-07-01       Impact factor: 6.860

6.  Long-term cognitive and cardiac outcomes after prenatal exposure to chemotherapy in children aged 18 months or older: an observational study.

Authors:  Frédéric Amant; Kristel Van Calsteren; Michael J Halaska; Mina Mhallem Gziri; Wei Hui; Lieven Lagae; Michèl A Willemsen; Livia Kapusta; Ben Van Calster; Heidi Wouters; Liesbeth Heyns; Sileny N Han; Viktor Tomek; Luc Mertens; Petronella B Ottevanger
Journal:  Lancet Oncol       Date:  2012-02-10       Impact factor: 41.316

7.  Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95.

Authors:  Anja Möricke; Alfred Reiter; Martin Zimmermann; Helmut Gadner; Martin Stanulla; Michael Dördelmann; Lutz Löning; Rita Beier; Wolf-Dieter Ludwig; Richard Ratei; Jochen Harbott; Joachim Boos; Georg Mann; Felix Niggli; Andreas Feldges; Günter Henze; Karl Welte; Jörn-Dirk Beck; Thomas Klingebiel; Charlotte Niemeyer; Felix Zintl; Udo Bode; Christian Urban; Helmut Wehinger; Dietrich Niethammer; Hansjörg Riehm; Martin Schrappe
Journal:  Blood       Date:  2008-02-19       Impact factor: 22.113

8.  An ethically justified practical approach to offering, recommending, performing, and referring for induced abortion and feticide.

Authors:  Frank A Chervenak; Laurence B McCullough
Journal:  Am J Obstet Gynecol       Date:  2009-09-17       Impact factor: 8.661

9.  Weekly epirubicin in the treatment of gestational breast cancer (GBC).

Authors:  Fedro A Peccatori; Hatem A Azim; Giovanna Scarfone; Angiolo Gadducci; Cristina Bonazzi; Oreste Gentilini; Viviana Galimberti; Mattia Intra; Marzia Locatelli; Barbara Acaia; Piero Rossi; Saverio Cinieri; Liliana Calabrese; Aron Goldhirsch
Journal:  Breast Cancer Res Treat       Date:  2008-08-20       Impact factor: 4.872

Review 10.  Cancer chemotherapeutic agents as human teratogens.

Authors:  Brady P Selig; James R Furr; Ryan W Huey; Colin Moran; Vinod N Alluri; Gregory R Medders; Christina D Mumm; H Gene Hallford; John J Mulvihill
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2012-07-31
View more
  3 in total

Review 1.  Reproductive outcomes following a stem cell transplant for a haematological malignancy in female cancer survivors: a systematic review and meta-analysis.

Authors:  Brigitte Gerstl; Elizabeth Sullivan; Jana Koch; Handan Wand; Angela Ives; Richard Mitchell; Nada Hamad; Antoinette Anazodo
Journal:  Support Care Cancer       Date:  2019-09-21       Impact factor: 3.603

2.  Low rates of pregnancy screening in adolescents before teratogenic exposures in a national sample of children's hospitals.

Authors:  Pooja Rao; Yimei Li; Kelly D Getz; Tamara P Miller; Yuan-Shung Huang; Jennifer J Wilkes; Alix E Seif; Rochelle Bagatell; Brian T Fisher; Clarisa Gracia; Richard Aplenc
Journal:  Cancer       Date:  2016-09-12       Impact factor: 6.860

3.  [Diagnosis and treatment of acute leukemia during pregnancy].

Authors:  N Peng; M Y Liang; Q Jiang
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2022-01-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.